{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:09:36Z","timestamp":1770750576097,"version":"3.50.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,10]]},"DOI":"10.7759\/cureus.103334","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T09:40:08Z","timestamp":1770716408000},"source":"Crossref","is-referenced-by-count":0,"title":["Transfusion-Related Iron Overload in Children With Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma: Addressing an Overlooked Treatment Complication"],"prefix":"10.7759","author":[{"given":"Nusa","family":"Matijasic Stjepovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izabela","family":"Kranjcec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnes","family":"Resic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Sila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Cavar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucija","family":"Ruzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeta","family":"Trbusic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasminka","family":"Stepan Giljevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16020367","article-title":"Iron overload in children with acute lymphoblastic and acute myeloblastic leukemia-experience of one center","volume":"16","author":"Sawicka-Zukowska M","year":"2024","unstructured":"Sawicka-Zukowska M, Kretowska-Grunwald A, Kania A, et al.. Iron overload in children with acute lymphoblastic and acute myeloblastic leukemia-experience of one center. Cancers (Basel). 2024, 16:10.3390\/cancers16020367","journal-title":"Cancers (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.111.1.91","article-title":"Iron overload in children who are treated for acute lymphoblastic leukemia estimated by liver siderosis and serum iron parameters","volume":"111","author":"Halonen P","year":"2003","unstructured":"Halonen P, Mattila J, Suominen P, Ruuska T, Salo MK, M\u00e4kipernaa A. Iron overload in children who are treated for acute lymphoblastic leukemia estimated by liver siderosis and serum iron parameters. Pediatrics. 2003, 111:91-6. 10.1542\/peds.111.1.91","journal-title":"Pediatrics"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1007\/s13312-018-1418-x","article-title":"Iron overload in children with leukemia receiving multiple blood transfusions","volume":"55","author":"Nair M","year":"2018","unstructured":"Nair M, Kuttath V, Nair AR, et al.. Iron overload in children with leukemia receiving multiple blood transfusions. Indian Pediatr. 2018, 55:962-5.","journal-title":"Indian Pediatr"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2014.05.002","article-title":"Number of erythrocyte transfusions is more predictive than serum ferritin in estimation of cardiac iron loading in pediatric patients with acute lymphoblastic leukemia","volume":"38","author":"Unal S","year":"2014","unstructured":"Unal S, Cetin M, Hazirolan T, et al.. Number of erythrocyte transfusions is more predictive than serum ferritin in estimation of cardiac iron loading in pediatric patients with acute lymphoblastic leukemia. Leuk Res. 2014, 38:882-5. 10.1016\/j.leukres.2014.05.002","journal-title":"Leuk Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22851","article-title":"Insidious iron burden in pediatric patients with acute lymphoblastic leukemia","volume":"56","author":"Eng J","year":"2011","unstructured":"Eng J, Fish JD. Insidious iron burden in pediatric patients with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2011, 56:368-71. 10.1002\/pbc.22851","journal-title":"Pediatr Blood Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000000887","article-title":"Iron overload in survivors of childhood cancer","volume":"40","author":"Trovillion EM","year":"2018","unstructured":"Trovillion EM, Schubert L, Dietz AC. Iron overload in survivors of childhood cancer. J Pediatr Hematol Oncol. 2018, 40:396-400. 10.1097\/MPH.0000000000000887","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25189","article-title":"Transfusion related iron overload in pediatric oncology patients treated at a tertiary care centre and treatment with chelation therapy","volume":"61","author":"Sait S","year":"2014","unstructured":"Sait S, Zaghloul N, Patel A, Shah T, Iacobas I, Calderwood S. Transfusion related iron overload in pediatric oncology patients treated at a tertiary care centre and treatment with chelation therapy. Pediatr Blood Cancer. 2014, 61:2319-20. 10.1002\/pbc.25189","journal-title":"Pediatr Blood Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000001849","article-title":"Transfusion-related iron overload in children with leukemia","volume":"43","author":"Cacciotti C","year":"2021","unstructured":"Cacciotti C, Athale U. Transfusion-related iron overload in children with leukemia. J Pediatr Hematol Oncol. 2021, 43:18-23. 10.1097\/MPH.0000000000001849","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-14-0292","article-title":"Characterization of transfusion-derived iron deposition in childhood cancer survivors","volume":"23","author":"Ruccione KS","year":"2014","unstructured":"Ruccione KS, Wood JC, Sposto R, Malvar J, Chen C, Freyer DR. Characterization of transfusion-derived iron deposition in childhood cancer survivors. Cancer Epidemiol Biomarkers Prev. 2014, 23:1913-9. 10.1158\/1055-9965.EPI-14-0292","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/08880018.2022.2098436","article-title":"Estimation of iron overload with T2*MRI in children treated for hematological malignancies","volume":"40","author":"Munikoty V","year":"2023","unstructured":"Munikoty V, Sodhi KS, Bhatia A, et al.. Estimation of iron overload with T2*MRI in children treated for hematological malignancies. Pediatr Hematol Oncol. 2023, 40:315-25. 10.1080\/08880018.2022.2098436","journal-title":"Pediatr Hematol Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.31254","article-title":"Risk of transfusion-related iron overload varies based on oncologic diagnosis and associated treatment: Retrospective analysis from a single pediatric cancer center","volume":"72","author":"Winzent-Oonk S","year":"2025","unstructured":"Winzent-Oonk S, Staley A, Alami V, et al.. Risk of transfusion-related iron overload varies based on oncologic diagnosis and associated treatment: Retrospective analysis from a single pediatric cancer center. Pediatr Blood Cancer. 2025, 72:e31254. 10.1002\/pbc.31254","journal-title":"Pediatr Blood Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2025.102977","article-title":"Transfusion-related iron overload in survivors of childhood cancer","volume":"117","author":"Reddy K","year":"2026","unstructured":"Reddy K, Fish JD, Eng J, Carlson CA, Ginsberg JP. Transfusion-related iron overload in survivors of childhood cancer. Blood Cells Mol Dis. 2026, 117:102977. 10.1016\/j.bcmd.2025.102977","journal-title":"Blood Cells Mol Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2009.0499","article-title":"The treatment of secondary hemochromatosis","volume":"106","author":"Gattermann N","year":"2009","unstructured":"Gattermann N. The treatment of secondary hemochromatosis. Dtsch Arztebl Int. 2009, 106:499-504, I. 10.3238\/arztebl.2009.0499","journal-title":"Dtsch Arztebl Int"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.39.450.193","article-title":"Iron metabolism and the liver with particular reference to the pathogenesis of haemochromatosis","volume":"39","author":"WI R","year":"1963","unstructured":"WI R, PI CS. Iron metabolism and the liver with particular reference to the pathogenesis of haemochromatosis. Postgrad Med J. 1963, 39:193-204. 10.1136\/pgmj.39.450.193","journal-title":"Postgrad Med J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12081921","article-title":"New entity-thalassemic endocrine disease: major beta-thalassemia and endocrine involvement","volume":"12","author":"Carsote M","year":"2022","unstructured":"Carsote M, Vasiliu C, Trandafir AI, et al.. New entity-thalassemic endocrine disease: major beta-thalassemia and endocrine involvement. Diagnostics (Basel). 2022, 12:10.3390\/diagnostics12081921","journal-title":"Diagnostics (Basel)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1345.006","article-title":"Survival and complications in thalassemia","volume":"1054","author":"Borgna-Pignatti C","year":"2005","unstructured":"Borgna-Pignatti C, Cappellini MD, De Stefano P, et al.. Survival and complications in thalassemia. Ann N Y Acad Sci. 2005, 1054:40-7. 10.1196\/annals.1345.006","journal-title":"Ann N Y Acad Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17839","article-title":"Guidelines for the monitoring and management of iron overload in patients with haemoglobinopathies and rare anaemias","volume":"196","author":"Shah FT","year":"2022","unstructured":"Shah FT, Porter JB, Sadasivam N, et al.. Guidelines for the monitoring and management of iron overload in patients with haemoglobinopathies and rare anaemias. Br J Haematol. 2022, 196:336-50. 10.1111\/bjh.17839","journal-title":"Br J Haematol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2021.102296","article-title":"Late hepatic toxicity surveillance for survivors of childhood, adolescent and young adult cancer: Recommendations from the international late effects of childhood cancer guideline harmonization group","volume":"100","author":"Bardi E","year":"2021","unstructured":"Bardi E, Mulder RL, van Dalen EC, et al.. Late hepatic toxicity surveillance for survivors of childhood, adolescent and young adult cancer: Recommendations from the international late effects of childhood cancer guideline harmonization group. Cancer Treat Rev. 2021, 100:102296. 10.1016\/j.ctrv.2021.102296","journal-title":"Cancer Treat Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13935","article-title":"Iron chelation therapy","volume":"110","author":"Bruzzese A","year":"2023","unstructured":"Bruzzese A, Martino EA, Mendicino F, et al.. Iron chelation therapy. Eur J Haematol. 2023, 110:490-7. 10.1111\/ejh.13935","journal-title":"Eur J Haematol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/cimb47010060","article-title":"Ferritin as an effective prognostic factor and potential cancer biomarker","volume":"47","author":"Szymulewska-Konopko K","year":"2025","unstructured":"Szymulewska-Konopko K, Resze\u0107-Gie\u0142a\u017cyn J, Ma\u0142eczek M. Ferritin as an effective prognostic factor and potential cancer biomarker. Curr Issues Mol Biol. 2025, 47:10.3390\/cimb47010060","journal-title":"Curr Issues Mol Biol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.10183","article-title":"Incidence of anemia in pediatric cancer patients in Europe: results of a large, international survey","volume":"39","author":"Michon J","year":"2002","unstructured":"Michon J. Incidence of anemia in pediatric cancer patients in Europe: results of a large, international survey. Med Pediatr Oncol. 2002, 39:448-50. 10.1002\/mpo.10183","journal-title":"Med Pediatr Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2023.01.020","article-title":"Iron overload following hematopoietic stem cell transplantation: prevalence, severity, and management in children and adolescents with malignant and nonmalignant diseases","volume":"29","author":"Cattoni A","year":"2023","unstructured":"Cattoni A, Capitoli G, Casagranda S, et al.. Iron overload following hematopoietic stem cell transplantation: prevalence, severity, and management in children and adolescents with malignant and nonmalignant diseases. Transplant Cell Ther. 2023, 29:271.e1-271.e12. 10.1016\/j.jtct.2023.01.020","journal-title":"Transplant Cell Ther"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.radcr.2024.01.059","article-title":"Choroid plexus and pituitary gland hemochromatosis induced by transfusional iron overload: two case reports","volume":"19","author":"Fujii H","year":"2024","unstructured":"Fujii H, Matsuki M, Hamakawa T, et al.. Choroid plexus and pituitary gland hemochromatosis induced by transfusional iron overload: two case reports. Radiol Case Rep. 2024, 19:1666-70. 10.1016\/j.radcr.2024.01.059","journal-title":"Radiol Case Rep"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-022-03366-y","article-title":"A challenging case of an adolescent and young adult patient with high-risk acute lymphoblastic leukemia: the need for a multidisciplinary approach: a case report","volume":"16","author":"Kranj\u010dec I","year":"2022","unstructured":"Kranj\u010dec I, Matija\u0161i\u0107 N, Abdovi\u0107 S, Hi\u017ear Ga\u0161par I, La Grasta Saboli\u0107 L, Jadrijevi\u0107-Cvrlje F. A challenging case of an adolescent and young adult patient with high-risk acute lymphoblastic leukemia: the need for a multidisciplinary approach: a case report. J Med Case Rep. 2022, 16:147. 10.1186\/s13256-022-03366-y","journal-title":"J Med Case Rep"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.22054","article-title":"Effect of the hemochromatosis mutations on iron overload among the indian \u03b2 thalassemia carriers","volume":"31","author":"Nadkarni AH","year":"2017","unstructured":"Nadkarni AH, Singh AA, Colaco S, Hariharan P, Colah RB, Ghosh K. Effect of the hemochromatosis mutations on iron overload among the indian \u03b2 thalassemia carriers. J Clin Lab Anal. 2017, 31:10.1002\/jcla.22054","journal-title":"J Clin Lab Anal"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06455.x","article-title":"A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease","volume":"136","author":"Vichinsky E","year":"2007","unstructured":"Vichinsky E, Onyekwere O, Porter J, et al.. A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease. Br J Haematol. 2007, 136:501-8. 10.1111\/j.1365-2141.2006.06455.x","journal-title":"Br J Haematol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004938","article-title":"Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study","volume":"6","author":"Kwiatkowski JL","year":"2022","unstructured":"Kwiatkowski JL, Hamdy M, El-Beshlawy A, et al.. Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study. Blood Adv. 2022, 6:1243-54. 10.1182\/bloodadvances.2021004938","journal-title":"Blood Adv"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-020-04196-y","article-title":"Combined chelation with high-dose deferiprone and deferoxamine to improve survival and restore cardiac function effectively in patients with transfusion-dependent thalassemia presenting severe cardiac complications","volume":"99","author":"Chuang TY","year":"2020","unstructured":"Chuang TY, Li JP, Weng TF, Wu KH, Chao YH. Combined chelation with high-dose deferiprone and deferoxamine to improve survival and restore cardiac function effectively in patients with transfusion-dependent thalassemia presenting severe cardiac complications. Ann Hematol. 2020, 99:2289-94. 10.1007\/s00277-020-04196-y","journal-title":"Ann Hematol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18366","article-title":"Agranulocytosis in patients with Diamond-Blackfan anaemia (DBA) treated with deferiprone for post-transfusion iron overload:aA retrospective study of the French DBA cohort","volume":"199","author":"Lecornec N","year":"2022","unstructured":"Lecornec N, Castex MP, R\u00e9guerre Y, et al.. Agranulocytosis in patients with Diamond-Blackfan anaemia (DBA) treated with deferiprone for post-transfusion iron overload:aA retrospective study of the French DBA cohort. Br J Haematol. 2022, 199:285-8. 10.1111\/bjh.18366","journal-title":"Br J Haematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/454002-transfusion-related-iron-overload-in-children-with-acute-lymphoblastic-leukemia-and-lymphoblastic-lymphoma-addressing-an-overlooked-treatment-complication","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T09:40:09Z","timestamp":1770716409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/454002-transfusion-related-iron-overload-in-children-with-acute-lymphoblastic-leukemia-and-lymphoblastic-lymphoma-addressing-an-overlooked-treatment-complication"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.103334","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,10]]}}}